NUVIANT MEDICAL INC. — Form D
NUVIANT MEDICAL INC. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2015-04-30. The offering totals $143K, of which $143K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-04-30
- Form: D
- Accession: 0001076542-15-000080
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $143K
- Amount sold: $143K
- Minimum investment: $1K
- Investors: 93
- Date of first sale: 2015-01-26
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-238960
Issuer
- Name: NUVIANT MEDICAL INC.
- CIK: 0001638919
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2014
- Address: 3824 CEDAR SPRINGS RD. #419, DALLAS, TX, 75219
- Phone: 469-222-2350
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| HARTNUT SPITAELS | Director | DALLAS, TX |
| Alexander Ruckdaeschel | Director | Burlington, NC |
| CHRISTOPHER R MILLER | Executive Officer | DALLAS, TX |
| David B Kaysen | Director | Waconia, MN |
| RONALD CONQUEST | Director | DALLAS, TX |
| BRIAN B BLISCHAK | Director | DALLAS, TX |
| BRIAN B BLISCHAK | Executive Officer | DALLAS, TX |
| WILLIAM ROSELLINI | Director | DALLAS, TX |
| WILLIAM ROSELLINI | Executive Officer | DALLAS, TX |
Other filings by this issuer (1)
More